This infographic depicts the essence of the (Medical Science Liaison) MSL universe. The data provided in this graphic are based on our extensive research on the Medical Affairs function, the Medical Science Liaison salary and activities, and KOL feedback studies. These metrics outline the general (average) profile of a typical MSL. Individual MSL roles will [...]
Are you wondering how to become a Medical Science Liaison (MSL)? A MSL connects life science organizations to industry thought leaders (or KOLs) by sharing scientific and clinical information on products and involving these KOLs in research, speaking or consulting activities. Here’s what you can expect from your journey of medical science liaison training and [...]
Research shows what European KOLs think of MSLs they interact with. Through the deployment of scientific field teams (MSLs), organizations’ intentions are to share medical and clinical knowledge of products with the thought leaders who in turn can spread the information to physician communities and ultimately enhance patient experiences. In the process, thought leaders become [...]
A new research study MSL Performance Metrics: Valuing the Role Throughout a Product's Lifecycle reveals key indicators on MSL performance reviews and identify the most common trends and perceptions among the medical affairs executives including how they see the 3 phases of MSL Performance Reviews. The full study presents an assessment of current practices, feedback from 37 [...]
The Instagram stars of therapeutic areas and disease management, Digital Opinion Influencers (DOIs) are a growing online presence that often can as effectively communicate and advocate for pharmaceutical solutions and products as Key Opinion Leaders (KOLs) do in more traditional channels (publications, conference presentations, perhaps even treating patients). The possibility of that very comparison makes [...]
Let's talk real world science! Leveraging real-world data and scientific evidence when making strategic decisions has never been more important—in the pharmaceutical world, at least. Though done here most convincingly, Arx Research isn’t the only research firm to notice and empirically confirm that physicians and thought leaders by and large want their discussions with pharma [...]
What KOLs think of MSLs? The good news is that everyone is doing a fairly good job! The bad news is…well there isn’t much bad news here. It seems KOLs really appreciate MSLs, maybe with just a few that don’t excel but no real bad apples! Overall ranking assessment of the quality of the relationships [...]
